alpelisib + fulvestrant PIK3CA Mutation Breast Carcinoma Recurrent, +2 more states Second line alpelisib, +1 more drug hormone therapy, +1 more type
cobimetinib ARAF Mutation, +6 more biomarkers Erdheim-Chester Disease, +2 more conditions First line, +1 more context cobimetinib targeted therapy
everolimus PIK3CA Mutation Erdheim-Chester Disease, +2 more conditions First line, +1 more context everolimus targeted therapy
sirolimus PIK3CA Mutation Erdheim-Chester Disease, +2 more conditions First line, +1 more context sirolimus targeted therapy
trametinib ARAF Mutation, +6 more biomarkers Erdheim-Chester Disease, +2 more conditions First line, +1 more context trametinib targeted therapy
Cancer Search
